Stanislav Gobec

About Stanislav Gobec

Stanislav Gobec, With an exceptional h-index of 54 and a recent h-index of 37 (since 2020), a distinguished researcher at Univerza v Ljubljani, specializes in the field of Medicinal Chemistry, Drug Discovery.

His recent articles reflect a diverse array of research interests and contributions to the field:

Boronic acid inhibitors of penicillin-binding protein 1b: serine and lysine labelling agents

The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions

Structural Optimization and Biological Evaluation of Isoxazolo[5,4-d]pyrimidines as Selective Toll-Like Receptor 7 Agonists

Molecular Mechanism of Labelling Functional Cysteines by Heterocyclic Thiones

Direct inhibitors of InhA with efficacy similar or superior to isoniazid in novel drug regimens for tuberculosis

Discovery of a fragment hit compound targeting D-Ala: D-Ala ligase of bacterial peptidoglycan biosynthesis

Mur ligase F as a new target for the flavonoids quercitrin, myricetin, and (–)-epicatechin

Novel quinolin-2-yl nitrones useful for the prevention and/or treatment of neurodegenerative diseases

Stanislav Gobec Information

University

Position

Faculty of Pharmacy

Citations(all)

9427

Citations(since 2020)

5109

Cited By

6436

hIndex(all)

54

hIndex(since 2020)

37

i10Index(all)

198

i10Index(since 2020)

145

Email

University Profile Page

Google Scholar

Stanislav Gobec Skills & Research Interests

Medicinal Chemistry

Drug Discovery

Top articles of Stanislav Gobec

Boronic acid inhibitors of penicillin-binding protein 1b: serine and lysine labelling agents

Journal of Enzyme Inhibition and Medicinal Chemistry

2024/12/31

Krištof Bozovičar
Krištof Bozovičar

H-Index: 1

Stanislav Gobec
Stanislav Gobec

H-Index: 32

The search for novel proline analogs for viscosity reduction and stabilization of highly concentrated monoclonal antibody solutions

International journal of pharmaceutics

2024/4/25

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Structural Optimization and Biological Evaluation of Isoxazolo[5,4-d]pyrimidines as Selective Toll-Like Receptor 7 Agonists

ACS omega

2024/1/4

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Matej Sova
Matej Sova

H-Index: 17

Molecular Mechanism of Labelling Functional Cysteines by Heterocyclic Thiones

ChemPhysChem

2024/1/2

Krištof Bozovičar
Krištof Bozovičar

H-Index: 1

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Direct inhibitors of InhA with efficacy similar or superior to isoniazid in novel drug regimens for tuberculosis

bioRxiv

2024

Discovery of a fragment hit compound targeting D-Ala: D-Ala ligase of bacterial peptidoglycan biosynthesis

Journal of enzyme inhibition and medicinal chemistry

2023/12/31

Matej Butala
Matej Butala

H-Index: 12

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Mur ligase F as a new target for the flavonoids quercitrin, myricetin, and (–)-epicatechin

Journal of computer-aided molecular design

2023/12

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Novel quinolin-2-yl nitrones useful for the prevention and/or treatment of neurodegenerative diseases

2023/11/30

N-((1-benzylpiperidin-3-yl) methyl)-n-(2-methoxyethyl) naphthalene-2-sulfonamide for the treatment of canine cognitive dysfunction and other forms of dementia in dogs

2023/10/19

Synthesis and Cholinesterase Inhibitory Activity of Selected Indole-Based Compounds.

Acta Chimica Slovenica

2023/10/1

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno) proteasome

Acta Pharmaceutica

2023/9/30

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Izidor Sosič
Izidor Sosič

H-Index: 17

Inhibition of MurA Enzyme from Escherichia coli by Flavonoids and Their Synthetic Analogues

ACS omega

2023/8/25

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Conjugates of monocyclic β-lactams and siderophore mimetics: a patent evaluation (WO2023023393)

2023/8/3

Alen Krajnc
Alen Krajnc

H-Index: 4

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Cathepsin inhibitors nitroxoline and its derivatives inhibit SARS-CoV-2 infection

Antiviral Research

2023/8/1

Optimization of triazolo [4, 5-d] pyrimidines towards human CC chemokine receptor 7 (CCR7) antagonists

European journal of medicinal chemistry

2023/5/5

8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases

Acta Pharmaceutica Sinica B

2023/5/1

Pseudo-irreversible butyrylcholinesterase inhibitors: Structure–activity relationships, computational and crystallographic study of the N-dialkyl O-arylcarbamate warhead

European journal of medicinal chemistry

2023/2/5

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Biological Evaluation of Valeriana Extracts from Argentina with Potent Cholinesterase Inhibition for the Treatment of Neurodegenerative Disorders and Their Comorbidities …

Pharmaceuticals

2023/1/16

Next-generation heterocyclic electrophiles as small-molecule covalent MurA inhibitors

Pharmaceuticals

2022/11/29

Janez Ilaš
Janez Ilaš

H-Index: 18

Stanislav Gobec
Stanislav Gobec

H-Index: 32

Fragment-sized thiazoles in fragment-based drug discovery campaigns: friend or foe?

ACS medicinal chemistry letters

2022/11/3

Stanislav Gobec
Stanislav Gobec

H-Index: 32

See List of Professors in Stanislav Gobec University(Univerza v Ljubljani)